Fact CheckerSign in

NCT06420193Completed

Evaluating Procedures for a Study of the AYA Survivors Coping and Emotional Needs Toolkit

Evaluating the Feasibility and Acceptability of Study Procedures for a Full Factorial Trial of the AYA Survivors Coping and Emotional Needs Toolkit (ASCENT)

Source: ClinicalTrials.gov · Last updated 10 Jul 2025

Brief summary (registry, in English)

The investigators developed a digital intervention that aims to help adolescent and young adult cancer survivors (AYAs) manage symptoms of depression. This tool includes daily mood tracking, a psychoeducational module about cancer and depression, four components that are based on evidence-based interventions for depression. The goal of this study is to evaluate the acceptability of procedures for a future trial in which the investigators will test which component or combination of components meaningfully contribute to improvements in depressive symptoms among AYAs. Additionally, the investigators will evaluate study feasibility as well as intervention acceptability, satisfaction, usability, and engagement.

Status (registry)
Completed
Study type
Interventional
Enrollment
16 (actual)
First submitted
7 May 2024
Start date
1 Oct 2024
Primary completion date
17 Jun 2025
Lead sponsor
East Carolina University
NCT number
NCT06420193

What you commit to

  • Study type: Interventional
  • Participants enrolled: 16
  • From 1 Oct 2024 to the primary completion date, 17 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Mental Health: Current diagnosis of severe or persistent mental illness

Other

  • Suicidality: Severe suicidal ideation (including plan and intent)

Who the study is looking for

  • Age at enrollment (adolescents 15-17, emerging adults 18-25, young adults 26-39)
  • Age at diagnosis (adolescents 12-17, emerging adults 15-25, young adults 15-39)
  • Time since completion of treatment: 1 month to 5 years
  • Language: Fluent in English (spoken and written)
  • Technology: Own smart phone with data plan

Age in the registry: 15 years to 39 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
East Carolina University
Coordinator of this site? Confirm its status
GreenvilleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.